Lv4
430 积分 2023-10-13 加入
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
5天前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
13天前
已完结
Exploring the next generation of antibody–drug conjugates
13天前
已完结
Antibody–drug conjugates come of age in oncology
13天前
已完结
HER2-targeted therapies beyond breast cancer — an update
14天前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
2个月前
已完结
Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer
3个月前
已完结
Facts and Hopes in Neoadjuvant Immunotherapy Combinations in Resectable Non–Small Cell Lung Cancer
3个月前
已完结
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer
3个月前
已完结
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives
3个月前
已完结
皖公网安备34019202002308
